Episode Details

WLY (John Wiley & Sons) reported Q4 FY2026 earnings on 2026-06-16. Stock fell 1.9% on the print. Here's the breakdown: Is WLY a buy, hold, or sell after this quarter? In this John Wiley & Sons (WLY) Q4 FY2026 earnings breakdown we cover the revenue and EPS print, the 8-quarter trend, segment detail, the free-cash-flow bridge, forward guidance, peer valuation, and management & earnings quality - ending with a clear price-aware Buy / Hold / Avoid Call and a Wall Street consensus comparison. If you follow Communication stocks or WLY earnings, this is the Q4 FY2026 deep dive. 🎧 Listen on Podbean: https://chargedalpha.podbean.com (also on Apple Podcasts & Spotify) 🔔 Subscribe for daily earnings deep-dives → @ChargedAlpha | Call tracker: chargedalpha.com THE CALL: HOLD (3/5 conviction, MODERATE) - CURRENT @ $43.33 - HOLD - BUY below $36.00 with $32.00 stop - AVOID above $50.00 TRIGGER: Two consecutive quarters of AI licensing revenue growth above 30% YoY OR Learning segment back to flat-or-better growth WINDOW: Through Q2 FY27 earnings (December 2026) TRACKER: chargedalpha.com WALL STREET CONSENSUS - Ratings: 0 Strong Buy / 1 Buy / 3 Hold / 1 Sell / 0 Strong Sell - HOLD - Median 12-month price target: $47.00 (range $36 - $55) - Charged Alpha vs consensus: IN LINE THESIS A 218-year-old academic publisher with a high-margin AI licensing engine compounding from $0 to ~$50M annually inside a stagnant top-line - Research segment monetizing scholarly corpus to AI labs, Learning segment fading. Bull lever: If AI licensing deal flow accelerates (IQVIA + OpenEvidence become templates for 5-10 more corporate AI partners), Research grows double digits and the consolidated story re-rates toward RELX's multiple. Key risk: Management's own wide FY27 EPS guide band ($0.86 spread) acknowledges they can't predict AI deal timing; if the next two quarters show flat AI revenue, the narrative-driven 53% rally unwinds. QUALITY CHECK - Management quality grade: B+ (Matthew Kissner stepped in as CEO during the Education Services divestiture and has executed cleanly on the AI-licensing pivot: IQVIA and OpenEvidence are landmark deals that legit.) - Earnings quality grade: B (GAAP vs adjusted EPS gap is wide ($0.85 vs $1.) CHAPTERS 0:00 Hook 0:13 The Year in One Chart 0:53 The Print 1:32 Beat Decomposition 2:19 The Trend 3:04 The Segments 3:52 The FCF Bridge 4:32 Margin Quality 5:07 Guidance & The Narrative Diff 5:55 Catalyst Calendar 6:45 Peer Dot-Plot 7:28 Valuation 8:02 Management & Earnings Quality 8:42 The Call - Verdict 9:25 The Call - Evidence 10:05 The Call - Supporting Figures KEY METRICS - Q4 FY2026 - Revenue: $0.44B (YoY +0.1%, beat est by +1.9%) - EPS: $1.37 (vs $1.31 est, beat +4.6%) - Operating margin: 20.1% - Free cash flow: $0.13B (30.2% margin) WLY Q4 FY2026: clean beat - adj EPS $1.37 vs $1.31, rev $443M vs $435M, AI licensing revenue ~$50M FY (up from $44M) anchored by IQVIA/OpenEvidence; Research +4% offset by Learning -5% on tough AI comp. Stock +8% premarket. FY27 EPS guide midpoint $3.21 BELOW $3.55 street with wide $0.86 band acknowledging AI-deal lumpiness. HOLD conv 3/5 at $43.33 - story is real but already up 53% YTD; next leg needs evidence AI compounds, not plateaus. NARRATIVE DIFF - what changed in management tone - Prior call: "Through the first nine months of fiscal 2026 we generated forty-two million dollars in AI-related revenue, surpassing the prior year's total with one quarter remaining." - This call: "AI revenue grew double digits to nearly fifty million dollars with a rapidly expanding recurring stream, anchored by landmark partnerships with IQVIA and OpenEvidence and a growing roster of corporate customers." - Tone shift: Story confirmed but not accelerated: AI is real and growing, but management's own FY27 guide says they cannot promise the same step-function in the new year. The midpoint-below-street guide is the tell - Wiley would rather under-promise on AI deal tim